Cipher Pharmaceuticals announces U.S. commercial entry through acquisition of … – Military Technologies

Cipher Pharmaceuticals announces U.S. commercial entry through acquisition of
Military Technologies
In connection with the offering, Cipher has issued Athyrium 600,000 common share purchase warrants. The warrants are exercisable at US$9.22 (equal to the five-day volume-weighted average price on the Toronto Stock Exchange prior to closing converted …

and more

…read more

Scroll to Top